A percolation phase transition controls complement protein coating of surfaces
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Abramson Cancer Center (2023 PFDL 1008128, SCR_022376, P30 016520)
- National Science Foundation (MRI 2215917)
- Pennsylvania Department of Health (W911NF1910240)
- National Institutes of Health (R01-HL160694, R01-HL-153510, 1R35GM136259, R01-NS-131279, 1R01CA244660, R01-HL-157189)
- National Center for Advancing Translational Sciences (UL1TR001878)
- American Heart Association (916172)
This publication has 48 references indexed in Scilit:
- C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infectionCell, 2023
- Complement activation in COVID-19 and targeted therapeutic options: A scoping reviewBlood Reviews, 2022
- Liposome composition in drug delivery design, synthesis, characterization, and clinical applicationAdvanced Drug Delivery Reviews, 2021
- The impact of antifouling layers in fabricating bioactive surfacesActa Biomaterialia, 2021
- Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunitiesAdvanced Drug Delivery Reviews, 2020
- Recent advancements in liposome technologyAdvanced Drug Delivery Reviews, 2020
- The Crown and the Scepter: Roles of the Protein Corona in NanomedicineAdvanced Materials, 2018
- Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology ModelsCPT: Pharmacometrics & Systems Pharmacology, 2015
- Evolution of the Complement System2014
- Material properties in complement activationAdvanced Drug Delivery Reviews, 2011